In both, NIVO + IPI and NIVO + Chemo arms, the OS prolongation effect was numerically larger with the higher tumor-cell PD-L1 expression subgroup, with no further enrichment of efficacy observed in any of the cutoff values higher than 1% (Online Resource 5). Here, CD274 is linked to neoplasm.